NO20053310D0 - Fremgangsmate og sammensetning til a behandle engstelse. - Google Patents

Fremgangsmate og sammensetning til a behandle engstelse.

Info

Publication number
NO20053310D0
NO20053310D0 NO20053310A NO20053310A NO20053310D0 NO 20053310 D0 NO20053310 D0 NO 20053310D0 NO 20053310 A NO20053310 A NO 20053310A NO 20053310 A NO20053310 A NO 20053310A NO 20053310 D0 NO20053310 D0 NO 20053310D0
Authority
NO
Norway
Prior art keywords
composition
treating anxiety
anxiety
treating
Prior art date
Application number
NO20053310A
Other languages
English (en)
Other versions
NO20053310L (no
Inventor
Janet Codd
Bernard Beer
Original Assignee
Nascime Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nascime Ltd filed Critical Nascime Ltd
Publication of NO20053310D0 publication Critical patent/NO20053310D0/no
Publication of NO20053310L publication Critical patent/NO20053310L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
NO20053310A 2002-12-04 2005-07-04 Fremgangsmate og sammensetning til a behandle engstelse. NO20053310L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43074002P 2002-12-04 2002-12-04
PCT/US2003/037714 WO2004050019A2 (en) 2002-12-04 2003-11-25 Method and compositions for treating anxiety

Publications (2)

Publication Number Publication Date
NO20053310D0 true NO20053310D0 (no) 2005-07-04
NO20053310L NO20053310L (no) 2005-08-29

Family

ID=32469522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053310A NO20053310L (no) 2002-12-04 2005-07-04 Fremgangsmate og sammensetning til a behandle engstelse.

Country Status (12)

Country Link
US (1) US20040192706A1 (no)
EP (1) EP1581230A2 (no)
JP (1) JP2006509789A (no)
KR (1) KR20050085386A (no)
CN (1) CN1720048A (no)
AU (1) AU2003297559A1 (no)
BR (1) BR0316192A (no)
CA (1) CA2507609A1 (no)
NO (1) NO20053310L (no)
PL (1) PL377357A1 (no)
RU (1) RU2005120749A (no)
WO (1) WO2004050019A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009013384A (es) * 2007-06-08 2010-01-25 Addrenex Pharmaceuticals Inc Formulacion de liberacion extendida, y metodo para tratar disregulacion adrenergica.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration

Also Published As

Publication number Publication date
KR20050085386A (ko) 2005-08-29
BR0316192A (pt) 2005-10-11
CA2507609A1 (en) 2004-06-17
PL377357A1 (pl) 2006-02-06
RU2005120749A (ru) 2006-01-20
AU2003297559A1 (en) 2004-06-23
JP2006509789A (ja) 2006-03-23
CN1720048A (zh) 2006-01-11
US20040192706A1 (en) 2004-09-30
WO2004050019A3 (en) 2004-08-12
EP1581230A2 (en) 2005-10-05
NO20053310L (no) 2005-08-29
WO2004050019A9 (en) 2012-03-22
WO2004050019A2 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
DK1409611T3 (da) Sammensætning og styringsfremgangsmåde til behandling af carbonhydrid
IS7045A (is) Tæki og aðferð til að framleiða háþrýstivetni
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
NO20021929L (no) Fremgangsmåte og anordning for brönnkomplettering
IS8204A (is) Tæki og aðferð til að hluta niður
DK2267930T3 (da) Fremgangsmåde og indretning til retransmission
DE602004025616D1 (de) Einrichtungssteuereinrichtung, -verfahren und -programm
DE60319787D1 (de) Montageverfahren und -vorrichtung
NO20034946L (no) Anordning og fremgangsmate for a komplettere bronnboringsforgreninger.
DK1997512T3 (da) Fremgangsmåder til behandling af TWEAK-relaterede tilstande
FI20020757A (fi) Suihkutusmenetelmä ja -laitteisto
DK1682351T3 (da) Fremgangsmåde og indretning til kombinationstryk
NO20040918L (no) Fremgangsmate og anordning for lagdelt modulasjon.
DK1426784T3 (da) Indretning og fremgangsmåde til positionsbestemmelse
NO20026182D0 (no) Fremgangsmåte og anordning for trykkstyrt sekvensregulering
FI20021560A (fi) Ohjausmenetelmä
NO20050503D0 (no) Fremgangsmate og anordning
IS7572A (is) Aðferð og efni til lækninga
DK1253248T3 (da) Rengöringsmaskine og fremgangsmåde til rengöring af ballast
DK1578738T3 (da) Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf
DK1703965T3 (da) Indretning, fremgangsmåde og anvendelse til at danne små partikler
NO20031378D0 (no) Gjengivelsesmetode, gjengivelsesanordning, registreringsmetode og registreringsanordning
DK1197257T3 (da) Fremgangsmåde og indretning til tilvejebringelse af varme arbejdsgasser
NO20052793D0 (no) Fremgangsmate og anordning for a varme opp tungtsmeltelige oksider
NO20031004L (no) Fremgangsmåte og anordning for demodulasjon